Novozymes spinout closes doors after years-long antibiotics effort
The Danish biotech company Adenium Biotech, that focuses on multi-resistant bacteria, has decided to pull the plug and go into voluntary liquidation.
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.
Try us for 14 days
Try a trial subscription for access to our quality journalism